BIO vs MTD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 26, 2026
BIO
MTD
Investment Advisor Scores
MTD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BIO | MTD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 41.841 | 29.4118 | MTD |
| PEG Ratio | 1.1905 | 2.8562 | BIO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -0.1% | 4.5% | MTD |
| Earnings Growth | 18.7% | 18.3% | BIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 32.7/100 | 52.2/100 | MTD |
| Profit Margin | 8.6% | 21.9% | MTD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BIO
MarkupPrice above SMA50, rising 50-day trend (8.2% over 20 days), RSI 79
MTD
MarkupPrice above SMA50, rising 50-day trend (9.3% over 20 days), RSI 55
Fundamentals Snapshot
| Metric | BIO | MTD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 38.8 | 27.1 |
| Trailing P/E | 46.5 | 31.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.5% | 0.6% |
| Operating Margin | 0.1% | 0.3% |
| EPS | 8.39 | 44.31 |
| Dividend Yield | — | — |